Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Sakar Healthcare Ltd

| Quarterly Financial Results Q3 FY 2025-26

BULLISH SENTIMENT

Report Source

⬤5th Feb 26

Summary : Sakar Healthcare reported strong Q3 FY26 results with significant revenue and profit growth, and a clean limited review report.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Total Expenses (Q3 FY26): INR 5989.77 lakh.
  2. Cost of Materials consumed (Q3 FY26): INR 3854.24 lakh.
  3. Employee benefits expense (Q3 FY26): INR 988.74 lakh.
  4. Revenue from operations (Q3 FY26): INR 7034.24 lakh.
  5. Revenue from operations (9M FY26): INR 18063.90 lakh.
  6. Paid-up equity shares capital: INR 2224.99 lakh.
  7. Reserves excluding Revaluation Reserves (FY25): INR 26073.12 lakh (Standalone).
  8. Disclosure of related party transactions is not applicable for this quarterly filing.
  9. Both standalone and consolidated results are presented.
  10. Sakar Oncology Private Limited is a wholly owned subsidiary.

Corporate Overview

  1. Primarily India, with corporate and registered offices in Ahmedabad, Gujarat.
  2. Healthcare and oncology services, operating in a single segment.
  3. Factual and compliant, reporting financial results and review.
  4. Single operating segment, no segment reporting.

Risk Factors

  1. Limited review scope, not full audit.
  2. No specific risks disclosed in report.
  3. Future economic conditions remain uncertain.
  4. Regulatory changes could impact operations.

Key Drivers

  1. Revenue from operations grew significantly.
  2. Profit for the period more than doubled.
  3. Earnings per share showed strong increase.
  4. Clean limited review report received.

Auditor’s Report

  1. Clean limited review report, no material misstatements identified.

Board Commentary

  1. Compliance with SEBI (LODR) Regulations, 2015.
  2. Compliance with Companies (Indian Accounting Standards) Rules, 2015.

Corporate Governance

  1. Audit committee reviewed the financial results.

Management Discussion & Analysis

Performance Drivers

  1. Significant increase in revenue from operations.
  2. Substantial growth in profit for the period.
  3. Improved earnings per share performance.
Sakar Healthcare Ltd (SAKAR) Quarterly Report Analysis & Insights | Dhanarthi